These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24894061)

  • 21. Hyaluronic Acid-Modified Cationic Lipid-PLGA Hybrid Nanoparticles as a Nanovaccine Induce Robust Humoral and Cellular Immune Responses.
    Liu L; Cao F; Liu X; Wang H; Zhang C; Sun H; Wang C; Leng X; Song C; Kong D; Ma G
    ACS Appl Mater Interfaces; 2016 May; 8(19):11969-79. PubMed ID: 27088457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Propaedeutic study for the delivery of nucleic acid-based molecules from PLGA microparticles and stearic acid nanoparticles.
    Grassi G; Coceani N; Farra R; Dapas B; Racchi G; Fiotti N; Pascotto A; Rehimers B; Guarnieri G; Grassi M
    Int J Nanomedicine; 2006; 1(4):523-33. PubMed ID: 17722283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and characterization of poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres with entrapped pneumotropic bacterial antigens.
    Kofler N; Ruedl C; Klima J; Recheis H; Böck G; Wick G; Wolf H
    J Immunol Methods; 1996 Jun; 192(1-2):25-35. PubMed ID: 8699019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surface-assembled poly(I:C) on PEGylated PLGA microspheres as vaccine adjuvant: APC activation and bystander cell stimulation.
    Hafner AM; Corthésy B; Textor M; Merkle HP
    Int J Pharm; 2016 Nov; 514(1):176-188. PubMed ID: 27863662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PLGA (85:15) nanoparticle based delivery of rL7/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: A promising alternate to traditional adjuvants.
    Singh D; Somani VK; Aggarwal S; Bhatnagar R
    Mol Immunol; 2015 Dec; 68(2 Pt A):272-9. PubMed ID: 26442664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvanticity Regulation by Biodegradable Polymeric Nano/microparticle Size.
    Jia J; Zhang W; Liu Q; Yang T; Wang L; Ma G
    Mol Pharm; 2017 Jan; 14(1):14-22. PubMed ID: 28043126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice.
    Jung T; Kamm W; Breitenbach A; Hungerer KD; Hundt E; Kissel T
    Pharm Res; 2001 Mar; 18(3):352-60. PubMed ID: 11442276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of protein-adjuvant coencapsulation in microparticles for vaccine delivery.
    Mathew S; Lendlein A; Wischke C
    Eur J Pharm Biopharm; 2014 Jul; 87(2):403-7. PubMed ID: 24747810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of poly(acryl starch) and poly(lactide-co-glycolide) microspheres as drug delivery system for a rotavirus vaccine.
    Sturesson C; Degling Wikingsson L
    J Control Release; 2000 Sep; 68(3):441-50. PubMed ID: 10974398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rational Design of PLGA Nanoparticle Vaccine Delivery Systems To Improve Immune Responses.
    Gu P; Wusiman A; Zhang Y; Liu Z; Bo R; Hu Y; Liu J; Wang D
    Mol Pharm; 2019 Dec; 16(12):5000-5012. PubMed ID: 31621331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of anionic nanoparticles and microparticles as vaccine delivery systems.
    Wendorf J; Chesko J; Kazzaz J; Ugozzoli M; Vajdy M; O'Hagan D; Singh M
    Hum Vaccin; 2008; 4(1):44-9. PubMed ID: 18438105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and characterisation of poly(lactide-co-glycolide) small particulate systems for the delivery of immunostimulant CpG oligonucleotide.
    Shakweh M; Fattal E
    J Nanosci Nanotechnol; 2006; 6(9-10):2811-20. PubMed ID: 17048487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation, characterization and evaluation of rotavirus encapsulated PLA and PLGA particles for oral vaccination.
    Nayak B; Panda AK; Ray P; Ray AR
    J Microencapsul; 2009 Mar; 26(2):154-65. PubMed ID: 18608800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles.
    Fischer S; Uetz-von Allmen E; Waeckerle-Men Y; Groettrup M; Merkle HP; Gander B
    Biomaterials; 2007 Feb; 28(6):994-1004. PubMed ID: 17118442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus E2 protein encapsulation into poly d, l-lactic-
    Roopngam P; Liu K; Mei L; Zheng Y; Zhu X; Tsai HI; Huang L
    Int J Nanomedicine; 2016; 11():5361-5370. PubMed ID: 27789948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses.
    Ma W; Chen M; Kaushal S; McElroy M; Zhang Y; Ozkan C; Bouvet M; Kruse C; Grotjahn D; Ichim T; Minev B
    Int J Nanomedicine; 2012; 7():1475-87. PubMed ID: 22619507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres.
    Shi L; Caulfield MJ; Chern RT; Wilson RA; Sanyal G; Volkin DB
    J Pharm Sci; 2002 Apr; 91(4):1019-35. PubMed ID: 11948541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developing solid particulate vaccine adjuvants: surface bound antigen favours a humoural response, whereas entrapped antigen shows a tendency for cell mediated immunity.
    Kirby DJ; Kaur R; Agger EM; Andersen P; Bramwell VW; Perrie Y
    Curr Drug Deliv; 2013 Jun; 10(3):268-78. PubMed ID: 23410072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of collagen-induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping type II collagen: a novel treatment strategy for induction of oral tolerance.
    Kim WU; Lee WK; Ryoo JW; Kim SH; Kim J; Youn J; Min SY; Bae EY; Hwang SY; Park SH; Cho CS; Park JS; Kim HY
    Arthritis Rheum; 2002 Apr; 46(4):1109-20. PubMed ID: 11953991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PLGA nanoparticles loaded with KMP-11 stimulate innate immunity and induce the killing of Leishmania.
    Santos DM; Carneiro MW; de Moura TR; Soto M; Luz NF; Prates DB; Irache JM; Brodskyn C; Barral A; Barral-Netto M; Espuelas S; Borges VM; de Oliveira CI
    Nanomedicine; 2013 Oct; 9(7):985-95. PubMed ID: 23603355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.